EN
HI
Genomic Valley Biotech Share Price
37.711.79 (4.98%)
Last updated on 23 Oct, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 26 Oct, 2026, Genomic Valley Biotech stock price is ₹37.71. During the trading session, the stock has moved between an intraday low of ₹37.71 and an intraday high of ₹37.71. Over the last 52 weeks, Genomic Valley Biotech has traded between ₹20.10 and ₹38.20.
The stock has recorded a trading volume of 2,994 shares,. Its Average Traded Price (ATP) is ₹37.71, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 604 @ ₹37.71.
Genomic Valley Biotech has an upper circuit limit of ₹39.59 and a lower circuit limit of ₹35.83. The total value traded stands at ₹1.13 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Genomic Valley Biotech also offers a dividend yield of 0%.
Genomic Valley Biotech Share Price Chart
Genomic Valley Biotech Share Key Metrics
Volume
2994.00
Market Cap
11.52 CR
LTQ@LTP
604@37.71
ATP
37.71
Var Margin
28.74 %
Circuit Range
35.83-39.59
Delivery %
100 %
Value
1.13 L
ASM/GSM
No
Market Lot
1
Genomic Valley Biotech Resistance and Support
Pivot 35.92
Resistance
First Resistance
35.92
Second Resistance
35.92
Third Resistance
35.92
Support
First Support
35.92
Second Support
35.92
Third Support
35.92
Genomic Valley Biotech Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
46.06%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
53.94%
Others
0%
Total Promoters
MAR '26
46.06%
JUN '26
46.06%
SEP '26
46.06%
Genomic Valley Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-30 | Quarterly Results |
| 2026-08-14 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-01-15 | Quarterly Results |
| 2025-10-15 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-12-06 | Others |
| 2024-10-07 | Quarterly Results |
| 2024-07-29 | Quarterly Results |
Genomic Valley Biotech News
Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Genomic Valley Biotech board of directors will convene on 30 October 2026 for financial results.
Oct 21 2026 13:00:58
Genomic Valley Biotech Ltd - 539206 - Disclosure Under Regulation 30 And Regulation 30A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI (LODR) Regulations')
Promoter Yogesh Agrawal has signed a Share Purchase Agreement to sell his entire 46.06% stake (14.07 lakh shares) in Genomic Valley Biotech to Pankaj Grover and Abhisek Gupta. The transaction will result in a change of management control and triggers a mandatory open offer.
Oct 20 2026 16:12:02
Genomic Valley Biotech Management
| Name | Position |
|---|---|
| Yogesh Agrawal | Managing Director & Chief Financial Officer |
| Parul Agrawal | Non Executive Director |
Genomic Valley Biotech Similar Stocks
Genomic Valley Biotech FAQs
The Buying Price of Genomic Valley Biotech share is 37.71 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Genomic Valley Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Genomic Valley Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Genomic Valley Biotech shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Genomic Valley Biotech shares is 0. Useful to assess the stock's value relative to its book value.
To assess Genomic Valley Biotech’s valuation compare Sector P/E, P/B which are 29.97 & 1.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Genomic Valley Biotech is 11.52 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Genomic Valley Biotech share price is 38.20 & 20.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Genomic Valley Biotech belongs to the Agriculture sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GVBL
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC